Long-Term Follow-Up of Patients Undergoing Catheter Ablation

This study is currently recruiting participants.

Verified by University of Oklahoma, January 2009

First Received: December 20, 2007 Last Updated: January 5, 2009 History of Changes

Sponsored by:	University of Oklahoma
Information provided by:	University of Oklahoma
ClinicalTrials.gov Identifier:	NCT00584558

Purpose

The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at the OU Medical Center.

Condition	Intervention
Arrhythmia	Procedure: Catheter Ablation

Genetics Home Reference related topics: Brugada syndrome short QT syndrome

MedlinePlus related topics: Arrhythmia

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Long-Term Follow-Up of Patients Undergoing Catheter Ablation

Further study details as provided by University of Oklahoma:

Primary Outcome Measures:

Arrhythmia recurrence [ Time Frame: 0-10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Complications [ Time Frame: 0-10 years ] [ Designated as safety issue: Yes ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	5000
Study Start Date:	December 2000
Estimated Study Completion Date:	November 2050
Estimated Primary Completion Date:	November 2050 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 Patients undergoing catheter ablation.	Procedure: Catheter Ablation Catheter Ablation of arrhythmias

Detailed Description:

The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at this institution, including recurrence of the ablated arrhythmia and any late complications.

Eligibility

Ages Eligible for Study:	2 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients undergoing catheter ablation at the OU Medical Center

Criteria

Inclusion Criteria:

Undergoing catheter ablation at the OU Medical Center

Exclusion Criteria:

Prisoners
Refusal to participate

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00584558

Contacts

Contact: Karen Beckman, MD

405-271-9696 ext 37536

Karen-Beckman@ouhsc.edu

Locations

United States, Oklahoma
OU Medical Center	Recruiting
Oklahoma City, Oklahoma, United States, 73104
Principal Investigator: Karen Beckman, MD

Sponsors and Collaborators

University of Oklahoma

Investigators

Principal Investigator:

Karen Beckman, MD

University of Oklahoma

More Information

No publications provided

Responsible Party:	University of Oklahoma Health Science Center ( Karen Beckman, M.D. )
Study ID Numbers:	09343
Study First Received:	December 20, 2007
Last Updated:	January 5, 2009
ClinicalTrials.gov Identifier:	NCT00584558 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Oklahoma:

Arrhythmia
Catheter Ablation

Study placed in the following topic categories:

Heart Diseases
Arrhythmias, Cardiac

Additional relevant MeSH terms:

Pathologic Processes
Heart Diseases
Cardiovascular Diseases
Arrhythmias, Cardiac

ClinicalTrials.gov processed this record on May 07, 2009